Health economic burden of refractory and recurrent Clostridioides difficile infection in the inpatient setting of the German healthcare system – the IBIS Study
The IBIS study contributes valuable insights to the health economic burden of refractory and recurrent CDI in the German inpatient setting and underlines the importance of effective first-line treatment to improve treatment outcomes and reduce overall costs related to CDI.
Authors
- Enrico Schalk (ORCID: https://orcid.org/0000-0003-1892-5098)
- Klaus‐Peter Hunfeld (ORCID: https://orcid.org/0000-0001-6507-8608)
- Philipp Solbach (ORCID: https://orcid.org/0000-0003-2708-3611)
- Marta Rebeca Cruz Aguilar
- Philipp A. Reuken (ORCID: https://orcid.org/0000-0002-7696-475X)
- Tobias Schmidt‐Wilcke (ORCID: https://orcid.org/0000-0002-7929-1079)
- Stefanie K. Gräfe (ORCID: https://orcid.org/0000-0001-7678-0179)
- Asad Ullah (ORCID: https://orcid.org/0000-0001-8122-4062)
- Stefan Pützfeld
- Stefan Schmiedel (ORCID: https://orcid.org/0000-0002-6910-8461)
- Maria J. G. T. Vehreschild (ORCID: https://orcid.org/0000-0003-0446-3224)
- Christoph Lübbert (ORCID: https://orcid.org/0000-0001-6942-5785)
- Katharina Giesbrecht
- M Schmitz-Rode
- Sebastian Wingen‐Heimann (ORCID: https://orcid.org/0000-0002-4232-6944)
- J. Conrad
Institutions
- Goethe University Frankfurt (DE)
- University of Cologne (DE)
- Institute for Sports Medicine (DE)
- Evangelisches Krankenhaus Kalk (DE)
- University Hospital Schleswig-Holstein (DE)
- University Hospital Leipzig (DE)
- University Hospital Frankfurt (DE)
- Jena University Hospital (DE)
- University Hospital Cologne (DE)
- University of Lübeck (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Journal of Hospital Infection
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.jhin.2025.03.011
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Merck Sharp and Dohme